Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1

Secondary managing bodies

logo ENSL logo ucb1

You are here: Home / Teams / Durantel D - HepVir / What's new for us? / Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method

Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method

Verrier et al., Antiviral Research, 2022 / Team HepVir

 

https://www.sciencedirect.com/science/article/pii/S0166354222000183?via%3Dihub

 

Filed under:
Navigation